You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH):鹽酸氨溴索注射液獲批上市
格隆匯 11-08 15:38

格隆匯11月8日丨珍寶島(603567.SH)公佈,近日,公司獲得國家藥監局下發的關於鹽酸氨溴索注射液的《藥品註冊證書》。鹽酸氨溴索具有促進粘液排除作用及溶解分泌物的特性,可促進呼吸道內粘稠分泌物的排除及減少粘液的滯留,因而促進排痰,改善呼吸狀況。

公司表示,公司獲得鹽酸氨溴索注射液《藥品註冊證書》,是公司持續對呼吸系統等重大疾病領域進行研發投入的結果,有利於進一步豐富公司的產品管線。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account